Project CBD recently helped to enlist large-scale CBD clinical study subjects to assess daily cannabidiol use’s effectiveness and safety. Contrary to the FDA’s warnings, that ValidCare clinical study’s preliminary findings lacked any evidence that cannabidiol caused liver disease. The Food and Drug Administration has previously warned CBD users about possible secondary effects, which included liver damage.
For more confidence about the data level for the safety of the liver, Project CBD re-seeks volunteers who regularly use CBD goods for a month-long clinical study. That would aid in advancing the understanding of CBD safety and science.
Every participant will get free samples such as soft gels or tinctures as part of that CBD research. Those who finish the whole study and offer blood samples can also get $100 gift cards.
For more details regarding volunteering as well as to apply to take part in it, you may want to contact the company that will conduct that 30-day-long experiment.
You will have to write about your hemp CBD product use, positive and negative effects, and other details with an application for that many days. After the experiment period, you may have to offer a sample of your blood for a liver functioning test at your local Quest diagnostic laboratory.
In earlier research and customers’ standard use, cannabidiol has shown to have negative secondary effects, such as dry mouth and diarrhea. Anyhow, those are not serious side effects because they would only last for a short period. On top of that, it is possible to cope with some cannabidiol side effects with certain tricks. An example is drinking much water before, during and after CBD use for the dry mouth issue.
It is also worth noting that laboratories in New Jersey, Rhode Island, and New York have different blood sample drawing-related regulations. Therefore, the participants who live in those states will have to visit Connecticut, Pennsylvania or Massachusetts labs for their liver test requirements.
Many CBD brands support the experiment, and they expect customers to do the same. Meanwhile, the US Food and Drug Administration seeks observational and clinical data for help with its CBD regulatory process. Taking part in this study possibly means adding to the present CBD knowledge base. That means you and several other customers can know more about cannabidiol’s safety and effectiveness at the very least.